Recommendation of the President – Buccolam (midazolam)

On 31 July 2025, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 102/2025 on the reimbursement of the medicinal product Buccolam (midazolam) in pharmacies on prescription for the prolonged treatment of acute seizures in adults

Publication in Public Information Bulletin (BIP) >>